← stocks-llm New chat

IRONWOOD PHARMA INC CLASS A (IRWD) — insider trading

Health Care · NASDAQ

IRONWOOD PHARMA INC CLASS A (IRWD) has 16 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 16 (latest 2026-07-07).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-07-07 Silver Ronald Officer (PFO & PAO) Open-market sale 127,890 $4.52 $578.1K Form 4
2026-06-16 Moukheibir Catherine Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 McHugh Julie Director Open-market sale 21,571 $3.73 $80.5K Form 4
2026-06-16 McHugh Julie Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 DENNER ALEXANDER J Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 Duane Jon R Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 Currie Mark G Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 Kessler Marla L Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-16 Shepard Jay Director Grant / award / vesting 63,481 $0.00 $0 Form 4
2026-06-15 DENNER ALEXANDER J Director Grant / award / vesting 4,065 $0.00 $0 Form 4
2026-05-19 Silver Ronald Officer (PFO & PAO) Grant / award / vesting 25,000 $0.00 $0 Form 4
2026-03-17 DENNER ALEXANDER J Director Open-market sale 5,800 $3.31 $19.2K Form 4
2026-03-17 DENNER ALEXANDER J Director Open-market sale 6,725,000 $3.05 $20.51M Form 4
2026-03-13 DENNER ALEXANDER J Director Grant / award / vesting 4,451 $0.00 $0 Form 4
2026-03-10 Martini Gregory S. Officer (Chief Financial Officer) Grant / award / vesting 136,612 $0.00 $0 Form 4
2026-03-10 John Minardo Officer (Chief Legal Officer) Grant / award / vesting 136,612 $0.00 $0 Form 4

Ask the chat about IRWD's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: IRONWOOD PHARMA INC CLASS A (IRWD).

Last updated 2026-07-07 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.